ICL 3.7: Lung Cancer Diagnosis and Management Flashcards Preview

Pulmonary Week 4 > ICL 3.7: Lung Cancer Diagnosis and Management > Flashcards

Flashcards in ICL 3.7: Lung Cancer Diagnosis and Management Deck (58)
Loading flashcards...
1

how much mortality is caused by lung cancer?

160,000 deaths each year in the United States and 1/4 of all deaths due to cancer

non–small-cell lung cancer (NSCLC) is 85% of cases

adenocarcinoma (60%), squamous cell carcinoma (20%), and large cell carcinoma (5%)

small-cell lung cancer (SCLC) - 15% of cases

2

which cancers are most lethal for men vs. women?

men: lung > prostate > colorectal

women: lung > breast > colorectal

lung cancer remains the top cancer killer

3

how does lung cancer develop?

normally, each lung comprises trillions of cells of different tissue types in a highly organized structure

a lung cancer is born when a certain set of genes mutates in a single airway epithelial cell

that cell then replicates in uncontrolled fashion, disrupts the lung organization and harms the host

filling the breathing space isn't what actually kills people....

4

what causes cancer?

carcinogens like cigarette smoke increase the rate of DNA adducts and or DNA strand breakage

toxins in cigarette smoke also increase cell death and inflammation which increased airway epithelial cell (AEC) (and DNA) replication rate

these increase replication rate which is even more compounded with old age which is bad because with faster replication, there are more errors

the carcinogens and toxins also cause higher rates of promutations which are bulky adducts added onto the nucleotide bases that aren't removed by nucleotide excision repair prior to DNA replication --> so then the replication machinery mis-reads the base with the bulky adduct on it and inserts the incorrect nucleotide and you get a mutation in the daughter strand!!

mutations can effect cell cycle control genes, apoptosis control genes, and key immune regulatory genes

5

how is cigarette smoke associated with lung cancer?

this is the major avoidable etiologic agent is an addictive product made and promoted for consumption by an industry

80-85% of cases caused by cigarette smoke inhalation

second hand smoke also associated with lung cancer risk

cigarette smoke components that contribute to cancer include:
1. thousands of carcinogens
Reactive oxygen species in actively combusting tobacco smoke

2. toxic substances that directly kill cells and induce inflammation

6

how is radon associated with lung cancer?

second most common avoidable cause of lung cancer (10% of cases)

noble (chemically inert) radioactive gas resulting from radioactive decay of uranium deep in earth crust

after passing through crust (because chemically inert) decays into charged alpha emitters (e.g. polonium)

when inhaled, the alpha particles may damage airway epithelial DNA

7

which occupational exposures can cause lung cancer?

1. asbestos

2. arsenic

3. indoor cooking fires, roofing fumes

8

what is the new potential risks that could lead to lung cancer?

inhalation of combusting cannabis

Δ 9 -tetrahydrocannabinol (THC), like nicotine, produces addiction

documented carcinogens in combusted cannabis

risk for lung cancer 2-6-fold increase in heavy marijuana smokers

9

how is cell turnover effected in lung cancer?

increased airway epithelial cell death rate due to

1. recurring exposure to cytotoxins in cigarette smoke

2. chronic inflammation and cytotoxins from macrophages and lymphocytes like COPD/chronic bronchitis or pulmonary fibrosis


there's also increased airway epithelial stem cell replication rate in response to increased death rate --> increasing age multiples this effect!

10

what is the genetic predisposition of lung cancer?

85-90% of heavy smokers do not develop lung cancer so clearly there's got to be some genetics involved too

over ten lung cancer risk variants significantly associated based on GWAS, each with low effect

nicotine receptor variants and telomerase variants are some of the non-familial things that we think are associated with lung cancer

there's also a very small familial component = Li-Froumeni syndrome

11

how does ineffective immune surveillance contribute to the development of lung cancer?

if an airway epithelial cell acquires driver mutation and multiple other mutations then the mutated protein products should be recognized as non-self but if the intrinsic and/or adaptive immune system function is sub-optimal then tumor cells proliferate faster than immune system can recognize and kill them

12

what are some of the causes of ineffective immune system function?

1. Age; immune function declines with age

2. AIDS (lung cancer is most common cancer cause of death)

3. therapeutic immunosuppresion (e.g. lung transplant patients)

4. the cell with driver mutation also acquires a mutation that enables secretion of a protein that inhibits T-cells at checkpoint

13

who is effected by cancer in non-smokers?

15-20% of lung cancer is in non-smokers and we have no idea why it happens

predominantly women, and asian --> some evidence for hormonal contribution, not consistent

predominantly adenocarcinoma so it's more likely to have EGF receptor mutation or ALK1 or ROS1 translocation; less likely to have KRAS mutation

14

how have we tried to prevent lung cancer since the 1960s?

percentage of smokers in the US population decreased 1965-2015 from 42.4% of the adult population in 1965 to <15% (13.7%) in 2018

lung cancer incidence decreasing in men and plateauing in women

remaining smoker group is enriched for variants in nicotine receptor gene

15

how is the FDA trying to regulate cigarettes?

cigarette smoke contains nicotine, a highly addictive substance

FDA is moving to regulate and reduce nicotine in cigarettes and regulate electronic nicotine delivery systems (ENDS) or e-cigarettes

16

how do you treat nicotine addicted patients?

1. identify, counsel, and treat patients with nicotine addiction

2. offer FDA-approved Nicotine replacement therapy (NRT)

- nicotine receptor agonist (vareniclin [Chantix])

- adrenergic/dopamine reuptake inhibitor: Bupropion (Zyban, Wellbutrin)

- nicotine replacement: patch, gum, inhalation

17

what are the rates of tobacco use in the US?

approximately 20% of U.S. adults used any tobacco product

cigarette smoking reached an all-time low (13.7%)

e-cigarette and smokeless tobacco product use prevalence increased --> marked increase in prevalence of e-cigarette use among adolescents

18

what is the argument for nicotine e-cigarettes as nicotine replacement therapy?

e-cigarettes are at least 95% less harmful to health than tobacco smoking

e-cigarettes more effective for smoking cessation than current FDA-approved nicotine replacement therapy when accompanied by behavioral support

e-cigarette group more likely than nicotine-replacement group to use assigned product at 52 weeks (80% [63 of 79 participants] vs. 9% [4 of 44 participants])

also, reduced cough and phlegm production

19

what is the problem with vaping THC products?

vaping products containing THC reported by 84% of cases

the issue is the addition of Vitamin E as diluting solution to cheat the consumer is implicated as primary cause of respiratory failure

some cases were associated with acute exogenous lipoid pneumonia (ELP) while others were caused by eosinophilic pneumonia and ARDS

20

at what government level is THC legalized?

THC products legalized by states but not federal government!

the states are poorly equipped to regulate and are not prepared for health hazards...

21

what are the 5 categories of symptoms associated with advanced lung cancer?

1. local symptoms: cough, hemoptysis, obstructive pneumonia

2. constitutional: weight loss fever

3. local invasion: Impingement or invasion of nerve, pleural/pericardial fluid

4. distant metastasis; bone pain, headache, pleural effusion

5. paraneoplastic; SIADH, neurological symptoms, hypercalcemia

22

what are the causes of morbidity in lung cancer?

1. proximal cancers: sub-types squamous, small cell --> less prevalent today due to advent of filtered cigarettes 60 years ago

they cause obstruction of major airways which leads to collapsed lungs; may be associated with effusion due to increased vacuum that draws fluid in from lymphatics

they also invade the major vessels and can cause massive hemoptysis and thrombosis

2. distal cancers: sub-type adenocarcinoma --> more prevalent today because carcinogens in filtered smoke delivered more peripherally

they cause effusion of fluid into pleural space; decreased oxygenation, pain, shortness of breath

they can also invade the chest leading to pain

3. metastases --> bone pain, brain mets (seizures, pain, loss of function)

23

how do you approach the management of a lung cancer patient?

1. history and PE

2. diagnostic testing/biopsy as required to establish diagnosis

3. tissue diagnosis

4. staging workup

5. stage established

6. multidisciplinary discussion and treatment planning; smoking cessation counseling

24

how are treatment decisions individualized?

treatment decisions are individualized, based on:

1. stage at presentation: earlier the stage, the better chance for cure.

2. SCLC vs NSCLC: different staging and management

3. tumor-cell biology factors: driver mutations, immune checkpoint inhibitor secretor, tumor mutation burden, etc.

4. patient-specific factors: overall health/performance status, age, co-morbidities, PFTs, wishes

25

what is the multidisciplinary approach to lung cancer treatment?

1. surgery if early

2. radiation teatment

3. systemic therapy: chemotherapy, targeted molecular agents, immunotherapy, etc.

26

what are the 3 goals of lung cancer treatment?

1. cure; feasible if early stage, overall health/performance status permissive

2. control disease/maintain QoL; if later stage and/or health non-permissive

3. palliation of symptoms; late stage, poor health, and/or intolerant of any treatment

27

what are the least invasive diagnostic procedures?

transthoracic fine needle aspirate

endobronchial ultrasound (EBUS) needle aspirate can be done if there's extension of the tumor into the mediastinum and the lymph nodes of the mediastinum)

28

what is the non-small cell TNM staging of lung cancer?

T = tumor size or anatomic extent

N = number of lymph nodes involved or levels of locoregional nodes involved

M = metastases beyond locoregional site

29

what is the purpose of staging lung cancer?

to compare people in the same stages in clinical trials

it's also critical to minimize confounding effects when assessing new drugs/treatments and providing patient with accurate prognosis

periodic re-evaluation of staging criteria takes into account new empiric information

30

what are the categories of T in the staging?

T1a = <1 cm
T1b = 1-2 cm
T1c = 2-3 cm

T2a = 2-4 cm
T2b = 4-5 cm

T3 = 5-7 cm
T4 = 7+ cm

the size of the tumor has a huge effect on the outcome of the cancer! the bigger the worse